Untitled

Early-Onset Bipolar Disorder 343Lopez-Larson, M. P., DelBello, M. P., Zimmerman, M. E., Schwiers, M. L., & Strakowski,S. M. (2002). Regional prefrontal gray and white matter abnormalities in bipolar disorder.Biological Psychiatry, 52(2), 93–100.Loscher, W., Fisher, J. E., Nau, H., & Honack, D. (1989). Valproic acid in amygdalakindledrats: Alterations in anticonvulsant efficacy, adverse effects and drug and metabolitelevels in various brain regions during chronic treatment. The Journal ofPharmacology and Experimental Therapeutics, 250(3), 1067–1078.Mamounas, L. A., Altar, C. A., Blue, M. E., Kaplan, D. R., Tessarollo, L., & Lyons,W. E. (2000). BDNF promotes the regenerative sprouting, but not survival, of injuredserotonergic axons in the adult rat brain. Journal of Neuroscience, 20(2), 771–782.Manji, H. K., & Lenox, R. H. (1994). Long-term action of lithium: A role for transcriptionaland posttranscriptional factors regulated by protein kinase C. Synapse, 16(1),11–28.Manji, H. K., & Lenox, R. H. (1999). Ziskind-Somerfeld Research Award. Protein kinaseC signaling in the brain: Molecular transduction of mood stabilization in the treatmentof manic-depressive illness. Biological Psychiatry, 46(10), 1328–1351.Manji, H. K., Moore, G. J., & Chen, G. (2000a). Clinical and preclinical evidence for theneurotrophic effects of mood stabilizers: Implications for the pathophysiology and treatmentof manic-depressive illness. Biological Psychiatry, 48(8), 740–754.Manji, H. K., Moore, G. J., & Chen, G. (2000b). Lithium up-regulates the cytoprotectiveprotein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effectsin manic depressive illness. Journal of Clinical Psychiatry, 61 Suppl 9, 82–96.Martenyi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002, March).Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry,63(3), 199–206.Mayberg, H. S. (1997). Limbic-cortical dysregulation: A proposed model of depression.Journal of Neuropsychiatry and Clinical Neurosciences, 9(3), 471–481.McInnis, M. G., McMahon, F. J., Chase, G. A., Simpson, S. G., Ross, C. A., & DePaulo,J. R., Jr. (1993). Anticipation in bipolar affective disorder [see comments]. AmericanJournal of Human Genetics, 53(2), 385–390.Miklowitz, D. J., George, E. L., Axelson, D. A., Kim, E. Y., Birmaher, B., Schneck, C.,et al. (2004). Family-focused treatment for adolescents with bipolar disorder. Journalof Affective Disorders, 82 Suppl 1, S113–128.Miklowitz, D. J., & Hooley, J. M. (1998). Developing family psychoeducational treatmentsfor patients with bipolar and other severe psychiatric disorders. A pathway from basicresearch to clinical trials. Journal of Marital and Family Therapy, 24(4), 419–435.Miklowitz, D. J., Simoneau, T. L., George, E. L., Richards, J. A., Kalbag, A., Sachs-Ericsson, N., et al. (2000). Family-focused treatment of bipolar disorder: 1-year effectsof a psychoeducational program in conjunction with pharmacotherapy. BiologicalPsychiatry, 48(6), 582–592.Moore, G. J., Bebchuk, J. M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I. B.,et al. (2000). Lithium increases N-acetyl-aspartate in the human brain: In vivo evidencein support of bcl-2’s neurotrophic effects? Biological Psychiatry, 48(1), 1–8.Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Manji, H. K. (2000). Lithiuminducedincrease in human brain grey matter. Lancet, 356(9237), 1241–1242.Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., Manji, H. K., & Menji, H. K. (2000).Lithium-induced increase in human brain grey matter. Lancet, 356(9237), 1241–1242.Nakata, K., Ujike, H., Sakai, A., Uchida, N., Nomura, A., Imamura, T., et al. (2003).Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolardisorder. Neuroscience Letters, 337(1), 17–20.